Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCC

Clinical trial NCT03746249 · WITHDRAWN

Trial details

NCT number: NCT03746249
Sponsor: Sun Yat-sen University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2018-12-17
Primary completion: 2019-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.